Class 4 Medicines Defect Information: PI Bezalip Mono 400mg Tablets (30)

Quadrant Pharmaceuticals Limited have informed the MHRA of an error with the Patient Information Leaflets (PILs) that have been packaged in various parallel imported batches.

MHRA drug alert date:  12 September 2022

MHRA drug alert link: 

https://www.gov.uk/drug-device-alerts/class-4-medicines-defect-information-quadrant-pharmaceuticals-limited-bezalip-mono-400mg-tablets-el-22-a-slash-38?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=c4d6884b-4d39-4d67-851d-d24ae91bb6dc&utm_content=immediately

This is a caution in use only we are not accepting stock returns - if any defective stock is found it should be returned directly to the manufacturer.

Further Information

For more information, medical or supply enquiries, please contact radoslaw.bandomir@maxearn.co.uk or natalie.harrison@hallohealthcaregroup.com

Recipients of this Medicines Notification should bring it to the attention of relevant contacts by copy of this notice. NHS regional teams are asked to forward this to community pharmacists and dispensing general practitioners for information.